NfL: Useful in Differential Diagnosis?
A meta-analysis of 47 studies suggests CSF NfL is particularly elevated in a select few, suggesting it could help in differential diagnosis.
ALL NEWS
285 RESULTS
Sort By:
- Most Recent
- Most Commented
Alzheimer's Association International Conference 2018
BAN2401 Removes Brain Amyloid, Possibly Slows Cognitive Decline On Target: Crenezumab Reduces Aβ Oligomers in CSF PET Ligand Lights Up AAIC, May Detect Synapse Loss in AD Could Better Blood Pressure Management Preserve Cognition? Focused Ultrasound ...
Gene Therapy Treats Mouse Models of Gaucher’s Disease
In knockouts that model the most severe form of Gaucher’s disease, replacing one gene calms neuroinflammation, reduces neurodegeneration, and extends lifespan.
Next-Gen Antisense and Small Protein-Protein Disruptors Benefit SOD1 Models
Oligonucleotides that suppress SOD1, and small molecules that limit its binding to the protein Derlin-1, delay disease onset and extend lifespan in rodent models of ALS.
$30 Million Venture Philanthropy Project for AD Biomarkers
Investors pledge new money for research into biomarkers that yield marketable tests.
Could Better Blood Pressure Management Preserve Cognition?
In SPRINT MIND trial, strict control of systolic pressure slashed MCI incidence by almost 20 percent.
Donepezil Not the Answer for Depressed MCI Patients
The acetylcholinesterase inhibitor failed to slow cognitive decline in people with both depression and mild cognitive impairment.
FDA Approves First RNAi Therapy
The drug, patisiran, targets messenger RNAs that cause transthyretin amyloidosis, a rare inherited neurodegenerative disease. Approval paves the way for other RNAi-based therapies.
Largest AD Whole-Exome Study to Date Finds Two New Risk Genes
A zinc-finger protein and a long noncoding RNA are now implicated in late-onset Alzheimer’s disease.
Memory Slips as Soon as Amyloid Appears, Two Decades Before Dementia
Sensitive cognitive tests detect deficits in preclinical Alzheimer’s even before an amyloid scan reads positive. And CSF Aβ42 drops a decade before that—pushing research ever farther into the preclinical phase.
Weeklong Chinese Challenge Reveals Subtle Memory Problems
At AAIC, technology improves on pen-and-paper tests of early cognitive decline. Think learning Chinese, think smartphone burst, think digital clock.
Brain Damage from Cardiovascular Disease Starts Earlier Than You Think
Data from two independent cohorts suggest that the risk to the brain from high blood pressure and cardiovascular disease begins in a person’s 40s or before.
Treating ALS in a Dish? Models Point to Drug Candidate for Sporadic Disease
The dopamine receptor agonist ropinirole emerged as the top hit in a screen of induced motor neurons.
Focused Ultrasound Breaches Blood-Brain Barrier in People with Alzheimer’s
Data from the first human study hints the procedure could help deliver drugs to the brain, or even work as a therapy in its own right. A flurry of animal studies presented at AAIC support the idea.
Cognitive Deficits Worse with ALS Stage
Neuropsychological impairments are common in amyotrophic lateral sclerosis, even more so for people at late stages of disease.
Current Filters
- Date Range : Jul 2018 to Jul 2019 x